This inventor holds 10 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Seed Research Institute, Op Bio Factory Co., Ltd., Okayama University. Active years: 2013-2023.
Company Filing History:
8 out of 9 
6 out of 8 
2 out of 138 
Years Active: 2013-2023
Title: Teruhiko Ishikawa: Innovator in Antifungal and Anticancer Agents
Introduction
Teruhiko Ishikawa is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of chemical synthesis, particularly in the development of antifungal and anticancer agents. With a total of 10 patents to his name, Ishikawa's work is recognized for its potential impact on medical treatments.
Latest Patents
One of Ishikawa's latest patents is a method for producing kakeromycin and its derivatives. This innovative production method showcases the antifungal activity and cytotoxicity of kakeromycin, positioning it as a promising candidate for new antifungal and anticancer therapies. The method involves chemical synthesis and includes a step of subjecting a specific compound to an oxidation reaction, which is crucial for the production of the desired derivatives.
Career Highlights
Throughout his career, Ishikawa has worked with notable companies such as Seed Research Institute Co., Ltd. and Op Bio Factory Co., Ltd. His experience in these organizations has allowed him to refine his expertise in chemical synthesis and patent development.
Collaborations
Ishikawa has collaborated with esteemed colleagues, including Morita Iwami and Tatsuya Kitaoka. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Teruhiko Ishikawa's innovative work in the field of chemical synthesis has the potential to revolutionize antifungal and anticancer treatments. His contributions, marked by a series of patents, highlight his role as a key figure in the ongoing quest for effective medical solutions.